Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
European tech manufacturing hubs are receiving record capital commitments aimed at reshoring critical silicon processing capacity.
Government Co-Investment Models
Public-private financing structures have lowered entry barriers for foundry operators, accelerating construction timelines for sub-5nm manufacturing plants.
Global demand for metabolic drugs prompts major drugmakers to acquire specialized contract development and manufacturing organizations.
Biopharmaceutical pipelines deploy lipid nanoparticle delivery platforms to address common cardiovascular and metabolic conditions.
High manufacturing costs and complex delivery logistics force biopharma firms to rethink commercialization strategies.
Clinical trial outcomes highlight enhanced delivery mechanisms that significantly mitigate liver toxicity in systemic treatments.
Phase III data shows significant efficacy in glycemic control and cardiovascular risk reduction among adult populations.
Contract development and manufacturing organizations pivot capital toward fill-finish capacity to address GLP-1 shortfalls.